Elma Hawkins
Fondateur chez Redpin Therapeutics, Inc.
Provenance du réseau au premier degré de Elma Hawkins
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
| Public Company | Biotechnology | 9 | |
EpiBone, Inc.
 EpiBone, Inc. Medical SpecialtiesHealth Technology Epibone, Inc. develops bone reconstruction solutions. Its technology utilizes a scan of the patient?s bone defect and the patient?s own stem cells to construct and cultivate an autologous-like bone graft that provides defect repair, and improves bone formation and regeneration. The company was founded by Nina Tandon, Gordana Vunjak-Novakovic, Sarindr Bhumiratana, Sidney Eisig, and Elisa Cimetta and is headquartered in Brooklyn, NY.
6
| Holding Company | Medical Specialties | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Elma Hawkins via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Integra LifeSciences Holdings Corp., Telios Pharmaceuticals, Inc. is a pharmaceutical company focused on research. The company is based in San Diego, CA. The company was founded by Iain David Dukes, Erkki Ruoslahti. Telios Pharmaceuticals was acquired by Integra LifeSciences Holdings Corp. on August 17, 1995 for $35 million. | Pharmaceuticals: Major | Founder | |
| ULTRALIFE CORPORATION | Electrical Products | Comptroller/Controller/Auditor | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| CITIGROUP INC. | Major Banks | Corporate Officer/Principal | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Rensselaer Polytechnic Institute | College/University | Doctorate Degree Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
Code Biotherapeutics, Inc.
 Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal | |
| The Rockefeller University | College/University | Director/Board Member Doctorate Degree | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Founder Director/Board Member | |
TARA Biosystems, Inc.
 TARA Biosystems, Inc. Packaged SoftwareTechnology Services TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY. | Packaged Software | Director/Board Member Founder | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Viriom, Inc.
 Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of Bath | College/University | Undergraduate Degree | |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member | |
VitroTech Corp.
 VitroTech Corp. Chemicals: SpecialtyProcess Industries VitroTech Corp. manufactures polymer additives. The company is headquartered in Santa Ana, CA. | Chemicals: Specialty | Director of Finance/CFO | |
| University of Belgrade | College/University | Graduate Degree | |
| ORGANOVO HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Organovo, Inc.
 Organovo, Inc. Medical/Nursing ServicesHealth Services Organovo, Inc. develops and supplies pharmaceutical products. It focuses on delivering human tissue printing technology and creating tissue on demand for research and surgical applications. The firm helps physicians and researchers fulfill the promise of regenerative medicine by overcoming problems in cardiovascular medicine, medical research and transplant medicine. The company was founded by Eric Michael David, Andras Forgacs, Gabor Forgacs and Keith Murphy in 2007 and is headquartered in San Diego, CA. | Medical/Nursing Services | Founder | |
Voxiva, Inc.
 Voxiva, Inc. Internet Software/ServicesTechnology Services Voxiva, Inc. provides interactive mobile health services. The firm technologies include SMS text messaging, interactive voice, email, mobile apps, devices, and the web to support prevention and wellness, disease management and adherence. The company was founded by Pamela Johnson, Paul Meyer, Anand Narasimhan and Melissa Torres in 2001 and is headquartered in Arlington, VA. | Internet Software/Services | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Xylyx Bio, Inc.
 Xylyx Bio, Inc. Pharmaceuticals: MajorHealth Technology Xylyx Bio, Inc. provides drug discovery and development services for patients. The company is based in Brooklyn, NY. The company was founded in 2016 by Gordana Vunjak-Novakovic, John D. O'Neill. The CEO is Andrea Nye. | Pharmaceuticals: Major | Founder | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal | |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| TRAWS PHARMA, INC. | Biotechnology | Chairman | |
Trawsfynydd Therapeutics, Inc.
 Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trawsfynydd Therapeutics, Inc. engages in discovering and developing antiviral medicines. The company is located in the US. | Miscellaneous Commercial Services | Founder | |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| UROGEN PHARMA LTD. | Biotechnology | Director of Finance/CFO | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 30 |
| Royaume-Uni | 5 |
| Allemagne | 2 |
| Suisse | 2 |
| Serbie , République de | 2 |
Sectorielle
| Health Technology | 20 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 5 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 163 |
| Founder | 70 |
| Corporate Officer/Principal | 42 |
| Director of Finance/CFO | 26 |
| Independent Dir/Board Member | 20 |
Relations les plus connectées
| Insiders | |
|---|---|
| Robert Langer | 88 |
| Anthony Evnin | 46 |
| Iain Dukes | 32 |
| Michael Handelman | 16 |
| Andras Forgacs | 16 |
| Brian McVeigh | 15 |
| Maria Fardis | 15 |
| Andrey Kozlov | 12 |
| Ryan Maynard | 10 |
| Molly Henderson | 10 |
| Manish Singh | 10 |
| Gordana Vunjak-Novakovic | 9 |
| Jeffrey Friedman | 9 |
| Abhinav Shukla | 9 |
| Dmitry Kuzmin | 9 |
- Bourse
- Insiders
- Elma Hawkins
- Connexions Sociétés
